Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-09 | Ms. Yanni received an A.B. from Wellesley College, a J.D. from Stanford Law School and an LL.M. from New York University. |
| 2020-04-08 | Ms. Yanni has served on boards of biopharmaceutical companies and was Vice President and Chief Licensing Officer at Merck & Co. She has an A.B., a J.D., and an LL.M. |
| 2021-04-06 | Ms. Yanni received an A.B. from Wellesley College, a J.D. from Stanford Law School and an LL.M. from New York University. |
| 2022-04-05 | Ms. Yanni received an A.B. from Wellesley College, a J.D. from Stanford Law School and an LL.M. in taxation from New York University. |
| 2023-04-06 | Ms. Yanni has served on the boards of Trevena, Inc., Pharming Group NV, Oncorus, Inc., and other biopharmaceutical companies. She was Vice President and Chief Licensing Officer at Merck & Co., Inc. and has a J.D. from Stanford Law School. |
| 2023-08-14 | Includes presently exercisable stock options for 111,633 shares of our common stock. No technical background mentioned. |
| 2024-01-08 | Includes presently exercisable, or exercisable within 60 days of December 29, 2023, stock options for 7,440 shares of our common stock. |
| 2024-04-02 | Ms. Yanni received an A.B. from Wellesley College, a J.D. from Stanford Law School and an LL.M. in taxation from New York University. |
Data sourced from SEC filings. Last updated: 2026-02-03